Christopher Earley, MD
Pulmonary Disease · Baltimore, MDNPI 1003857384
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pulmonary disease clinicians in MD, where the typical reported total is $830.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 7 payments — averaging $36,271 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- American Regent$254K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 297 pulmonary disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 32 | $507,124 |
| XywavSodium,calcium,mag,pot Oxybate | 25 | $496,022 |
| Sodium Oxybate | 11 | $208,801 |
| AdderallDextroamphetamine/Amphetamine | 14 | $22,060 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 76 | $9,846 |
| Methadone Hcl | 517 | $7,217 |
| Morphine Sulfate ErMorphine Sulfate | 87 | $7,131 |
| Dextroamphetamine Sulfate | 36 | $5,323 |
| Gabapentin | 178 | $3,608 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 58 | $2,645 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $2,389 |
| Fentanyl | 15 | $2,194 |
| Modafinil | 27 | $2,099 |
| Methylphenidate Hcl | 17 | $1,357 |
| Ramelteon | 11 | $1,293 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Baltimore
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Lonny YarmusBaltimore$582K
- Robert WiseBaltimore$389K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
- Kathryn RobinettBaltimore$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.